Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 1
1998 1
2000 1
2004 1
2006 1
2007 1
2008 1
2018 1
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Unresectable Vulvar Carcinoma"
Page 1
Human papillomavirus and nonhuman papillomavirus pathways to vulvar squamous cell carcinoma: A review.
Nitecki R, Feltmate CM. Nitecki R, et al. Curr Probl Cancer. 2018 Sep;42(5):476-485. doi: 10.1016/j.currproblcancer.2018.06.008. Epub 2018 Jul 5. Curr Probl Cancer. 2018. PMID: 30093165 Review.
Vulvar squamous cell carcinoma (VSCC) is a rare tumor of the female genital tract. ...In the most recent publication from the International Society of the Study of Vulvovaginal Disease (ISSVD), there is a distinction between high-risk vulvar lesions associate …
Vulvar squamous cell carcinoma (VSCC) is a rare tumor of the female genital tract. ...In the most recent publication from the …
High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity.
Rishi A, Rollins M, Ahmed KA, Hunt DC, Sarkar P, Fernandez DC, Hoffman MS, Apte SM, Shahzad MMK, Chon HS, Chern JY, Wenham RM, Montejo ME. Rishi A, et al. Gynecol Oncol. 2020 Feb;156(2):349-356. doi: 10.1016/j.ygyno.2019.11.027. Epub 2019 Nov 23. Gynecol Oncol. 2020. PMID: 31771865
INTRODUCTION: To evaluate clinical outcomes, pattern of failure, and toxicity after high-dose intensity-modulated radiation therapy (IMRT) for advanced vulvar cancer. METHODS: In this IRB approved retrospective study, the charts of women with histologically confirmed, non- …
INTRODUCTION: To evaluate clinical outcomes, pattern of failure, and toxicity after high-dose intensity-modulated radiation therapy (IMRT) f …
Carcinoma of the vulva.
Stehman FB, Look KY. Stehman FB, et al. Obstet Gynecol. 2006 Mar;107(3):719-33. doi: 10.1097/01.AOG.0000202404.55215.72. Obstet Gynecol. 2006. PMID: 16507947 Review.
The objective of this review is to summarize the published data about squamous carcinoma of the vulva and to identify promising areas for future investigation. Rather than the routine use of complete radical vulvectomy, a radical wide excision of the vulvar l …
The objective of this review is to summarize the published data about squamous carcinoma of the vulva and to identify promisin …
Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group.
Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Moore DH, et al. Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):79-85. doi: 10.1016/s0360-3016(98)00193-x. Int J Radiat Oncol Biol Phys. 1998. PMID: 9747823 Clinical Trial.
METHODS AND MATERIALS: Seventy-three evaluable patients with clinical Stage III-IV squamous cell vulvar carcinoma were enrolled in this prospective, multi-institutional trial. ...Using this strategy of preoperative, split-course, twice-daily radiation combine …
METHODS AND MATERIALS: Seventy-three evaluable patients with clinical Stage III-IV squamous cell vulvar carcinoma were enrolle …
Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study.
Montana GS, Thomas GM, Moore DH, Saxer A, Mangan CE, Lentz SS, Averette HE. Montana GS, et al. Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1007-13. doi: 10.1016/s0360-3016(00)00762-8. Int J Radiat Oncol Biol Phys. 2000. PMID: 11072157 Clinical Trial.
PURPOSE: To determine if patients with carcinoma of the vulva, with N2/N3 lymph nodes, could undergo resection of the lymph nodes and primary tumor following preoperative chemo-radiation. ...CONCLUSION: High resectability and local control rates of the lymph nodes w …
PURPOSE: To determine if patients with carcinoma of the vulva, with N2/N3 lymph nodes, could undergo resection of the lymph no …
Carcinoma of the vulva: combined modality treatment.
Montana GS. Montana GS. Curr Treat Options Oncol. 2004 Apr;5(2):85-95. doi: 10.1007/s11864-004-0041-3. Curr Treat Options Oncol. 2004. PMID: 14990203 Review.
Along with this recognition has come the realization that although some patients can be cured with one of these modalities alone, the judicious combination of these modalities can result in better outcome. Carcinoma of the vulva, a disease that presents challenges w …
Along with this recognition has come the realization that although some patients can be cured with one of these modalities alone, the judici …
Comparison of outcome measures in patients with advanced squamous cell carcinoma of the vulva treated with surgery or primary chemoradiation.
Landrum LM, Skaggs V, Gould N, Walker JL, McMeekin DS. Landrum LM, et al. Gynecol Oncol. 2008 Mar;108(3):584-90. doi: 10.1016/j.ygyno.2007.11.010. Epub 2007 Dec 26. Gynecol Oncol. 2008. PMID: 18155755
METHODS: Patients diagnosed with stage III and IV squamous cell carcinoma of the vulva from 1990 to 2006 were identified for retrospective analysis at a single institution. ...RESULTS: Sixty-three patients with stage III (n=47) and IV (n=16) carcinoma of the …
METHODS: Patients diagnosed with stage III and IV squamous cell carcinoma of the vulva from 1990 to 2006 were identified for r …
Management of locally advanced squamous cell carcinoma of the vulva.
Hoffman MS, Greenberg H, Roberts WS, Fiorica JV, LaPolla JP, Barton DP, Cavanagh D. Hoffman MS, et al. J Gynecol Surg. 1991 Fall;7(3):175-82. doi: 10.1089/gyn.1991.7.175. J Gynecol Surg. 1991. PMID: 10149781 Review.
Carcinoma of the vulva is an uncommon malignancy, accounting for 5% of gynecologic cancers. ...The use of primary radiotherapy for carcinoma of the vulva remains controversial but may be the only option available when the patient has unresectable …
Carcinoma of the vulva is an uncommon malignancy, accounting for 5% of gynecologic cancers. ...The use of primary radiotherapy …
Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva.
Russell AH, Mesic JB, Scudder SA, Rosenberg PJ, Smith LH, Kinney WK, Townsend DE, Trelford JD, Taylor MH, Zukowski CL, et al. Russell AH, et al. Gynecol Oncol. 1992 Oct;47(1):14-20. doi: 10.1016/0090-8258(92)90068-t. Gynecol Oncol. 1992. PMID: 1427394 Clinical Trial.
Reasons for patient referral for nonsurgical management included the presence of initially unresectable disease (5 patients), disease extent which would have necessitated partial or total exenteration if treated surgically (9 patients), disease extent predictive of …
Reasons for patient referral for nonsurgical management included the presence of initially unresectable disease (5 patients), disease …
Multimodality approach to a massive carcinoma of the vulva.
Podczaski E, Stryker J, Banducci D, Kaminski P, Sorosky J, Larson E, Degeest K, Mortel R. Podczaski E, et al. Eur J Gynaecol Oncol. 1990;11(6):415-9. Eur J Gynaecol Oncol. 1990. PMID: 2086225
The presentation, combination therapy and clinical course of a patient with a massive vulvar carcinoma are described. Therapeutic aspects in the treatment of such advanced malignancies are considered. A multimodality approach to locally advanced, unresecta …
The presentation, combination therapy and clinical course of a patient with a massive vulvar carcinoma are described. T …